Biopharmaceuticals, known colloquially as biopharma, are the point at which biotechnology and pharmaceutical manufacturing meet. Biopharma is the application of living organisms or extractions, by-products or components of living organisms, to prevent, relieve, or treat diseases.
Management Forum’s biopharma training courses provide an extensive series of training opportunities covering a variety of topics, including the development of biopharmaceuticals, clinical trial requirements, manufacture, regulations and applicable standards. Our courses also provide insight into the use of emerging technologies and state-of-the-art processes.
Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book
In-house & bespoke training
A two-day seminar providing an essential overview of biosmilars and how they differ from the original biological product.
Rated by attendees to the public programme
Typically presented by Andrew Willis (bio)
Typical duration: 2 days | |
Pricing from £800 per attendee | |
Delivery: collaborative classroom |
In-house & bespoke training
An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.
Rated by attendees to the public programme
Typically presented by
Robert Alvarez (bio)
and 6 more leading experts
Typical duration: 3 days | |
Pricing from £1,200 per attendee | |
Delivery: collaborative classroom |
In-house & bespoke training
The regulatory requirements for Biological drug products are complex, and pharmaceutical companies are continuously under pressure to ensure regulatory compliance from drug discovery to post-marketing surveillance.
This course has been designed to help you navigate the complex regulatory requirements for biological drugs, including ATMPs. It will clearly depict the differences between small and large molecules and the development approaches which reflect the type of molecule. It will address the key aspects of the CTD, look at the CMC regulatory requirements during different stages of development, and discuss the importance of change control.
Rated by attendees to the public programme
Typically presented by Andrew Willis (bio)
Typical duration: 2 days | |
Pricing from £800 per attendee | |
Delivery: collaborative classroom |
In-house & bespoke training
This course has been designed to provide an essential overview of the critical factors when working with the FDA (Food and Drug Administration). For those short on time this course is for you, as you will receive a focused and comprehensive overview of the key strategic considerations when making applications to the FDA.
Typically presented by Andrew Willis (bio)
Typical duration: 1 day | |
Pricing from £450 per attendee | |
Delivery: collaborative classroom |